Oncology News

Patients who undergo primary tumor resection as an initial treatment for synchronous colorectal liver metastases are at increased risk for progressive disease, according to data presented at the American Society of Colon and Rectal Surgeons Annual Meeting in Phoenix.

Patients who undergo primary tumor resection as an initial treatment for synchronous colorectal liver metastases are at increased risk for progressive disease, according to data presented at the American Society of Colon and Rectal Surgeons Annual Meeting in Phoenix.

Heavy alcohol consumption and obesity increase the risk for liver-related morbidity and death, while metabolic risk factors also elevate the risk for hepatocellular carcinoma, according to data presented at the International Liver Congress in Amsterdam.

Patients with cirrhosis and hepatocellular carcinoma experienced similar survival and tumor recurrence rates after treatment with either liver resection or radiofrequency ablation in a recent study.

Patients with chronic HBV treated with long-term entecavir developed hepatocellular carcinoma significantly less frequently than untreated controls in a recent study.

People who regularly drink coffee may be half as likely to develop liver cancer as those who never or rarely consume coffee, according to a recent meta-analysis.

Obese patients with colorectal liver metastasis were more likely to develop steatohepatitis or steatosis than nonobese patients in a recent study.

Poor screening for hepatocellular carcinoma occurs frequently among patients with chronic HCV and advanced fibrosis and can lead to tumor diagnosis at a late stage, according to recent results.

The addition of transcatheter arterial chemoembolization to radiofrequency ablation extended survival in patients with hepatocellular carcinoma, according to results of a prospective randomized study.

The use of gadoxetic acid as a contrast agent for magnetic resonance can improve the sensitivity of hepatocellular carcinoma diagnosis in patients with cirrhosis, according to recent results.